Impact of donor type in patients with AML given allogeneic hematopoietic cell transplantation after low-dose TBI-based regimen
Purpose: We assessed the impact of donor type in acute myeloid leukemia (AML) patients
transplanted with 2 Gy total body irradiation (TBI)-based nonmyeloablative conditioning …
transplanted with 2 Gy total body irradiation (TBI)-based nonmyeloablative conditioning …
[HTML][HTML] Impact of allogeneic stem cell transplantation in first complete remission in acute myeloid leukemia: a national population-based cohort study
LSG Østgård, JL Lund, JM Nørgaard… - Biology of Blood and …, 2018 - Elsevier
To examine the outcomes of allogeneic stem cell transplantation (HSCT) in first complete
remission (CR1) compared with chemotherapy alone in a population-based setting, we …
remission (CR1) compared with chemotherapy alone in a population-based setting, we …
Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for …
T Miyamoto, K Nagafuji, T Fujisaki, N Uchida… - International Journal of …, 2018 - Springer
We prospectively compared outcomes of autologous stem cell transplantation (ASCT)
versus high-dose cytarabine (HiDAC) consolidation as post-remission therapy for favorable …
versus high-dose cytarabine (HiDAC) consolidation as post-remission therapy for favorable …
What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease?
Background Acute graft‐versus‐host disease (aGVHD) is a major complication of allogeneic
haematopoietic stem cell transplantation (HSCT). With new promising therapies, survival …
haematopoietic stem cell transplantation (HSCT). With new promising therapies, survival …
[PDF][PDF] Leucemia mieloide aguda
F Leyto-Cruz - Rev Hematol, 2018 - academia.edu
The acute myeloid leukemia (AML) is the most common acute leukemia in adults. The risk
factors of AML are varied and involve genetic and acquired aspects. In Mexico there is no …
factors of AML are varied and involve genetic and acquired aspects. In Mexico there is no …
[PDF][PDF] Иерархическая структура стромального микроокружения кроветворной ткани в норме и при заболеваниях системы крови
ИН Шипунова - Москва, 2018 - blood.ru
Во взрослом костном мозге (КМ) кроветворение поддерживается и регулируется
стромальным микроокружением. Известно, что кроветворная система имеет четкую …
стромальным микроокружением. Известно, что кроветворная система имеет четкую …
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15–60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA …
F Baron, M Stevens-Kroef, M Kicinski, G Meloni… - Annals of …, 2018 - Springer
The presence of cytogenetic clonal heterogeneity has been associated with poor prognosis
in patients with acute myeloid leukemia (AML). Here, we reassessed this association. The …
in patients with acute myeloid leukemia (AML). Here, we reassessed this association. The …
Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission
J Vydra, C Šálek, J Schwarz, P Žák, J Novák… - … Myeloma and Leukemia, 2018 - Elsevier
Background We retrospectively analyzed data from 310 patients with acute myeloid
leukemia with intermediate-risk cytogenetics in first complete remission (CR1) to evaluate …
leukemia with intermediate-risk cytogenetics in first complete remission (CR1) to evaluate …
Эффективность высокодозной консолидации и аутологичной трансплантации костного мозга в первой ремиссии острого миелоидного лейкоза
ИА Самородова, СН Бондаренко, ВН Овечкина… - …, 2018 - cyberleninka.ru
Введение. Вопрос выбора наиболее адекватной стратегии лечения острого
миелоидного лейкоза (ОМЛ) в случаях, когда по какимлибо причинам невозможно …
миелоидного лейкоза (ОМЛ) в случаях, когда по какимлибо причинам невозможно …
The role of stem cell graft derived natural killer cells in regulating patient outcomes from allogeneic haematopoietic stem cell transplantation
L Maggs - 2018 - etheses.bham.ac.uk
Myeloid and lymphoid malignancies are potentially curable through a graft versus
leukaemia (GvL) effect following allogeneic haematopoietic stem cell transplantation. Whilst …
leukaemia (GvL) effect following allogeneic haematopoietic stem cell transplantation. Whilst …